Literature DB >> 19168420

Evaluation of beneficial effects of antioxidant properties of aqueous leaf extract of Andrographis paniculata in STZ-induced diabetes.

Anilkumar M Dandu1, Naseeruddin M Inamdar.   

Abstract

The beneficial effects of antioxidant properties Andrographis paniculata (Andrographis) were studied in the diabetic animals. Hyperglycemia, characteristic feature of diabetes mellitus leads to decreased antioxidant defense and hence development of oxidative stress, which in involved in the etiology of development of diabetic complications. The evidences suggest that good glycemic control and/or use of antioxidants may play an important role in the prevention of complications associated with diabetes. Diabetes was induced with single intraperitoneal injection of streptozotocin (45 mg/kg, i.p) dissolved in freshly prepared citrate buffer (pH 4.5), resulted in elevation of blood glucose levels, decrease in the superoxide dismutase and catalase activity. Oral administration of Andrographis (400 mg/kg, p.o) resulted in significant decrease in the blood glucose levels and increase in the activity of SOD and catalase. In conclusion Andrographis decreased the blood glucose levels in diabetic animals may be due to its antioxidant properties.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19168420

Source DB:  PubMed          Journal:  Pak J Pharm Sci        ISSN: 1011-601X            Impact factor:   0.684


  3 in total

1.  Antidiabetic and antihiperlipidemic effect of Andrographis paniculata (Burm. f.) Nees and andrographolide in high-fructose-fat-fed rats.

Authors:  Agung Endro Nugroho; Mohamad Andrie; Ni Kadek Warditiani; Eka Siswanto; Suwidjiyo Pramono; Endang Lukitaningsih
Journal:  Indian J Pharmacol       Date:  2012-05       Impact factor: 1.200

2.  Experimental and Clinical Pharmacology of Andrographis paniculata and Its Major Bioactive Phytoconstituent Andrographolide.

Authors:  Thanasekaran Jayakumar; Cheng-Ying Hsieh; Jie-Jen Lee; Joen-Rong Sheu
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-24       Impact factor: 2.629

3.  Prospective, Randomized, Open-Label, Blinded End Point, Two-Arm, Comparative Clinical Study to Evaluate the Efficacy and Safety of a Fixed Ayurvedic Regimen (FAR) as Add-on to Conventional Treatment in the Management of Mild and Moderate COVID-19 Patients.

Authors:  Arun Gupta; Sasibhushan Vedula; Ruchi Srivastava; Sanjay Tamoli; Narendra Mundhe; D N Wagh; Sanjay Batra; Manoj Patil; Hiren Baburao Pawar; Rajiva K Rai
Journal:  J Pharm Bioallied Sci       Date:  2021-05-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.